[1] Walter P,Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science,2011,334(6059):1081-1086. [2] Ron D,Walter P. Signal integration in 9the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol,2007, (87):519-529. [3] Todd DJ,Lee AH,Glimcher LH. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol,2008,8(9):663-674. [4] Zhao LH,Ackerman SL. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol,2006,18(4):444-452. [5] Rao RV,Hermel E,Castro-Obregon S,et al. Coupling endoplasmic reticulum stress to the cell death program. Biol Chem,2001,276(36):33869-33874. [6] Calfon M,Zeng H,Urano F,et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature,2002,420(6912):202. [7] Lee K,Tirasophon W,Shen X,et al. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev,2002,16(4):452-466. [8] Yoshida H,Matsui T,Yamamoto A,et al. XBP1mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell,2001,107(7):881-891. [9] Acosta-Alvear D,Zhou Y,Blais A,et al. XBP1 controls diverse cell type-and condition-specific transcriptional regulatory networks. Mol Cell,2007,27(1):53-66. [10] Lee AH,Iwakoshi NN,Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Bio1,2003,23(21):7448-7459. [11] Urano F,Wang X,Bertolotti A,et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science,2000,287(5453):664-666. [12] Nishitoh H,Matsuzawa A,Tobiume K. et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev,2002,16(11):1345-1355. [13] Upton JP,Wang L,Han D,et al. IRE1αcleaves select microRNAs during ER stress to derepress translation of proapoptotic caspase-2. Science,2012,338(6108):818-822. [14] Harding HP,Zhang Y,Zheng H,et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell,2003,11(3):619-633. [15] Lange PS,Chavez JC,Pinto JT,et al. ATF4 is an oxidative stress-inducible,prodeath transcription factor in neurons in vitro and in vivo. Exp Med,2008,205(5):1227-1242. [16] Novoa I,Zeng H,Harding HP. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α.Cell Biol,2001,153(5):1011-1022. [17] Tsaytler P,Harding HP,Ron D,et al. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science,2011,332(6025):91-94. [18] Schindler AJ,Schekman R.In vitro reconstitution of ER-stress induced ATF6 transport in COPII vesicles. Proc Natl Acad Sci USA,2009,106(42):17775-17780. [19] Haze K,Yoshida H,Yanagi H,et al. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell,1999,10(11):3787-3799. [20] Ye J,Rwson RB,Komuro R,et.al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell,2000,6(6):1355-1364. [21] Hetz C,Chevet E,Harding HP. Targeting the unfolded protein response in disease. Natrue Reviews,2013,9(12):703-718. [22] Ozcan U,Yilmaz E,Ozcan L,et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science,2006,313(5790):1137-1140. [23] Ozcan L,Ergin AS,Lu A,et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab,2009,9(1):35-51. [24] Xiao C,Giacca A,Lewis GF. Sodium phenylbutyrate,a drug with known capacity to reduce endoplasmic reticulum stress,partially alleviates lipidinduced insulin resistance and β-cell dysfunction in humans. Diabetes,2011,60(3):918-924. [25] Kars M,Yang L,Gregor MF,et al. Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes,2010,59(8):1899-1905. [26] Ben M,Alfany F,Martel C,et al. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis,2010,1(7):e52. [27] Qi X,Hosoi T,Okuma Y,et al. Sodium 4-phenylbutyrate protects against cerebral ischemic injury. Mol. Pharmacol,2004,66(4):899-908. [28] Cross BC, Bond PJ, Sadowski PG,et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc Natl Acad Sci USA,2012,109(15):E869-E878. [29] Mimura N,Fulciniti M,Gorgun G,et al. Blockade of XBP1 splicing by inhibition of IRE1αis a promising therapeutic option in multiple myeloma. Blood,2012,119(24):5772-5781. [30] Papandreou I,Denko NC,Olson M,et al. Identification of an IRE1αendonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood,2011,117(4):1311-1314. [31] Volkmann K,Lucas JL,Vuga D,et al. Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease. Biol Chem,2011,286(14):12743-12755. [32] Ri M,Tashiro E,Oikawa d,et al. Identification of toyocamycin, an agent cytotoxic for multiple myeloma cells,as a potent inhibitor of ER stress-induced XBP1mRNA splicing. Blood Cancer,2012,2(7):e79. [33] Ali MMU,Bagratuni T,Davenport EL,et al. Structure of the Ire1 autophosphorylation complex and implications for theunfolded protein response. EMBO,2011,30(5):894-905. [34] Bouchecareilh M,Higa A,Fribourg S,et al. Peptides derived from the bifunctional kinase/RNase enzyme IRE1αmodulate IRE1αactivity and protect cells from endoplasmic reticulum stress. FASEB,2011,25(9):3115-3129. [35] Axten JM,Medina JR,Feng YH,et al. Discoveryof7- methyl-5- (1-{[3-(trifluoromethyl)phenyl]acetyl}- 2,3-dihydro-1H-indol-5-yl)-7H-p yrrolo[2,3-d]pyrimidin-4-amine(GSK2606414),a potent and selective first-in-class inhibitor of protein kinase R(PKR)-like endoplasmic reticulum kinase(PERK). Med Chem,2012,55(7):7193-7207. [36] Atkins C,Liu Q,Minthorn E,et al. Characterization of a novel PERK kinase inhibitor with anti-tumor and anti-angiogenic activity. Cancer Res,2013,73(6):1993-2002. [37] Sidrauski C,Acosta AD,Khoutorsky A,et al. Pharmacological brake-release of mRNA translation enhances cognitive memory. Elife,2013,2:e00498. [38] Costa MM,Sossin WS,Klann,E,et al. Translational control of long-lasting synaptic plasticity and memmory. Neuron,2009,61(1):10-26. [39] Chou TF,Brown SJ,Minond D,et al. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc Natl Acad Sci USA,2011,108(3):4834-4839. [40] Polucci P,Magnaghi P,Angiolini M,et al. Alkylsulfanyl-1,2, 4-triazoles,a new class of allosteric valosine containing protein inhibitors. Med Chem,2013,56(2):437-450. [41] Witt J,Marks WJ Jr. An update on gene therapy in Parkinson’s disease. Curr Neurol Neurosci Rep,2011,11(4)362-370. [42] Gorbatyuk MS,Knox T,Lavail MM,et al. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proc Natl Acad Sci USA,2010,107(13):5961-5966. [43] Hu Y,Park KK,Yang L,et al. Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells. Neuron,2012,73(3):445-452. [44] Gorbatyuk MS,Shabashvili A,Chen W,et al. Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease. Mol Ther,2012,20(7):1327-1337. [45] Sado M,Yamasaki Y,Iwanaga T,et al. Protective effect against Parkinson’s disease-related insults through the activation of XBP1. Brain Res,2009,1257:16-24. [46] Moreno JA,Radford H,Peretti D,et al. Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature, 2012, 485(7399):507-511. |